Share on StockTwits

Veeva Systems (NASDAQ:VEEV) Director Young A. Sohn sold 27,500 shares of the stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $20.00, for a total transaction of $550,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Veeva Systems (NASDAQ:VEEV) traded down 1.11% during mid-day trading on Monday, hitting $19.67. 568,160 shares of the company’s stock traded hands. Veeva Systems has a one year low of $17.85 and a one year high of $49.00. The stock’s 50-day moving average is $24.33 and its 200-day moving average is $32.70. The company has a market cap of $2.455 billion and a price-to-earnings ratio of 132.60.

Veeva Systems (NASDAQ:VEEV) last released its earnings data on Tuesday, March 4th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.01. The company had revenue of $62.80 million for the quarter, compared to the consensus estimate of $58.00 million. During the same quarter in the previous year, the company posted $0.05 earnings per share. The company’s revenue for the quarter was up 57.8% on a year-over-year basis. Analysts expect that Veeva Systems will post $0.24 EPS for the current fiscal year.

A number of analysts have recently weighed in on VEEV shares. Analysts at Morgan Stanley upgraded shares of Veeva Systems from an “equal weight” rating to an “overweight” rating in a research note on Wednesday, April 2nd. They now have a $40.00 price target on the stock. They noted that the move was a valuation call. Analysts at Deutsche Bank raised their price target on shares of Veeva Systems from $42.00 to $44.00 in a research note on Wednesday, March 5th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $44.00.

Veeva Systems Inc (NASDAQ:VEEV) which provides industry-specific, cloud-based software solutions for the life sciences industry.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.